Ashwani Verma
Stock Analyst at UBS
(0)
# 2914
Out of 5,291 analysts
69
Total ratings
50.00%
Success rate
4.91%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals | Upgrades: Buy | 145 179 | 122.99 | 45.54% | 6 | Mar 7, 2025 | |
Alkermes | Upgrades: Neutral | n/a | n/a | n/a | 3 | Mar 4, 2025 | |
Teva Pharmaceutical ... | Maintains: Buy | 30 27 | 15.05 | 79.4% | 8 | Jan 30, 2025 | |
Neurocrine Bioscienc... | Maintains: Strong Buy | 162 176 | 113.11 | 55.6% | 6 | Jan 30, 2025 | |
Exelixis | Maintains: Neutral | 30 34 | 36.7 | -7.36% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 14 | 8.03 | 74.35% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 415 475 | 306.88 | 54.78% | 4 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 106 114 | 68.08 | 67.45% | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 56 | 33.19 | 68.73% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | 0.84 | 78.57% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 27.6 | 95.65% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | 131.81 | -40.07% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 23 | 17.06 | 34.82% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 118.33 | -11.27% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 31.36 | -10.71% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 35.13 | 130.57% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 61 92 | 43.2 | 112.96% | 4 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 65.66 | -89.34% | 1 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | n/a | n/a | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 8.68 | 38.25% | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 1.36 | 1002.94% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | n/a | n/a | 3 | Aug 4, 2022 |